Long-Term Outcomes in SLE at Peking University People's Hospital

Recruiting now

Conditions studied: Systemic Lupus Erythematosus

In brief

This study aims to prospectively follow patients diagnosed with Systemic Lupus Erythematosus (SLE) at Peking University People's Hospital, assessing long-term outcomes such as disease activity, organ involvement, survival, and quality of life. Findings will support individualized patient management and contribute to understanding disease progression in the Chinese population.

Key facts

Study ID

NCT07005479

Run by

Peking University People's Hospital

People needed

1000

Starts

2020-05-21

Expected to finish

2032-05-20

Last updated by the study team

2025-06-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients must meet at least one of the following classification criteria for Systemic Lupus Erythematosus (SLE):
• The 1997 American College of Rheumatology (ACR) Revised Classification Criteria; The 2012 Systemic Lupus International Collaborating Clinics (SLICC) Classification Criteria; The 2019 EULAR/ACR Classification Criteria for SLE. All patients must be over the age of 18 and competent to provide written consent.

You may not qualify if…

• Patients less than 18 years of age and patients who are unable to consent are excluded from the study.

Where it is running

• Department of Rheumatology and Immunology, Peking University People's Hospital — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.